Analysts Offer Insights on Real Estate Companies: Sachem Capital (SACH) and Global Medical REIT (GMRE)

Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Sachem Capital (SACH – Research Report) and Global Medical REIT (GMRE – Research Report).

Sachem Capital (SACH)

JonesTrading analyst Jason Weaver reiterated a Hold rating on Sachem Capital on August 5. The company’s shares closed last Wednesday at $1.16, close to its 52-week low of $1.00.

According to TipRanks.com, Weaver has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -6.4% and a 46.8% success rate. Weaver covers the NA sector, focusing on stocks such as Alpine Income Property Trust Inc, Franklin BSP Realty Trust, and Seven Hills Realty Trust.

Sachem Capital has an analyst consensus of Hold, with a price target consensus of $1.25.

See the top stocks recommended by analysts >>

Global Medical REIT (GMRE)

Colliers Securities analyst Barry Oxford maintained a Buy rating on Global Medical REIT yesterday and set a price target of $8.00. The company’s shares closed last Wednesday at $6.50.

According to TipRanks.com, Oxford is a 1-star analyst with an average return of -0.6% and a 44.3% success rate. Oxford covers the NA sector, focusing on stocks such as Bluerock Homes Trust, Inc. Class A, Alpine Income Property Trust Inc, and Strawberry Fields REIT Inc.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Global Medical REIT with a $8.95 average price target.

Read More on SACH:

• Sachem Capital Corp. Reports Q2 2025 Financial Results
• Sachem Capital’s Earnings Call: Mixed Results and Strategic Moves
• Sachem Capital reports Q2 EPS 2c, consensus 2c
• Sachem Capital Completes $100M Senior Notes Placement
• Sachem Capital closes $100M of senior secured notes